EUVIMEDEUVIMED entdecken
Crossref

Secondary oral squamous cell carcinoma following haematopoietic stem cell transplantation

Faaris Zaki iD, Martina Shephard, Robert Danby, Rachel Pawson, Andy Peniket, Katharine Sheppard, Rubeta N Matin

Clinical and Experimental Dermatology · 2024

DOI: 10.1093/ced/llae157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Faaris Zaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Carcinoma, Squamous Cell, Graft vs Host Disease, Mouth Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the cases of 10 patients with oral squamous cell carcinoma (SCC) post-haematopoietic stem cell transplant (HSCT). Median latency from HSCT to oral SCC diagnosis was 10 years (range: 4–17 years), with 90% (9/10) reporting a history of chronic graft-versus-host disease (cGVHD) and 40% (4/10) exhibiting active severe manifestations of oral GvHD. Clinical findings at diagnosis included induration, ulceration, tenderness, bleeding, hyperkeratosis, speckling and lymphadenopathy. The tongue and buccal mucosa were the most common sites affected. The disease stage at presentation ranged from T1N0M0 to T4N2M0. Management included surgical resection in 90% (9/10) of patients with or without chemotherapy and/or radiotherapy. The median follow-up for the cohort was 1 year, with a 50% (5/10) mortality rate. SCC-specific mortality was 30% (3/10). Our data highlight the importance of regular, active oral and cutaneous surveillance of patients post-HSCT in specialized dermatology clinics, irrespective of GvHD severity and length of iatrogenic immunosuppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCarcinoma, Squamous CellGraft vs Host DiseaseMouth NeoplasmsHumansMaleFemaleMiddle AgedAdultAgedNeoplasms, Second PrimaryYoung Adult

Autor:innen und Institutionen

  • Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Department of Oral Medicine, University College Hospital, London, UK.
  • Anthony Nolan Research Institute, London, UK.
  • Department of Dermatology, Churchill Hospital, Oxford, UK.

ORCID-Profile: Faaris Zaki

Zitieren

APA

Zaki, F., Shephard, M., Danby, R., Pawson, R., Peniket, A., Sheppard, K., & Matin, R. N. (2024). Secondary oral squamous cell carcinoma following haematopoietic stem cell transplantation. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae157

Vancouver

Zaki F, Shephard M, Danby R, Pawson R, Peniket A, Sheppard K, et al. Secondary oral squamous cell carcinoma following haematopoietic stem cell transplantation. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae157

BibTeX
@article{Zaki2024,
  author = {Zaki, Faaris and Shephard, Martina and Danby, Robert and Pawson, Rachel and Peniket, Andy and Sheppard, Katharine and Matin, Rubeta N},
  title = {Secondary oral squamous cell carcinoma following haematopoietic stem cell transplantation},
  journal = {Clinical and Experimental Dermatology},
  year = {2024},
  doi = {10.1093/ced/llae157}
}
Kostenlos starten →